Kathleen A. Cooney

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Epidemiology, Genetics, Molecular Biology, Oncology
Google:
"Kathleen Cooney"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Harper J, Hunt T, Choudry M, et al. (2023) Clinician interest in clinical decision support for PSA-based prostate cancer screening. Urologic Oncology
Wei J, Beebe-Dimmer J, Shi Z, et al. (2022) Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate
Trendowski MR, Sample C, Baird T, et al. (2022) Germline Variants in DNA Damage Repair Genes and Among Black Patients With Early-Onset Prostate Cancer. Jco Precision Oncology. 6: e2200460
Shi Z, Zhan J, Wei J, et al. (2022) Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations. European Urology Open Science. 45: 23-30
Harper JB, Greenberg SE, Hunt TC, et al. (2022) Initial outcomes and insights from a novel high-risk prostate cancer screening clinic. The Prostate
Xu J, Shi Z, Wei J, et al. (2022) KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression. Prostate Cancer and Prostatic Diseases
Na R, Wei J, Sample CJ, et al. (2021) The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients. British Journal of Cancer
Bancroft EK, Page EC, Brook MN, et al. (2021) A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. The Lancet. Oncology
Shi Z, Lu L, Resurreccion WK, et al. (2021) Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis. The Prostate
Wei J, Yang W, Shi Z, et al. (2021) Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. The Prostate
See more...